Latest Breaking News On - Generic formulations - Page 2 : comparemela.com

Biocon registers Rs 660cr net profit, consolidated revenue of Rs 4,519cr in Q3

Biocon Ltd, the Bengaluru-based pharmaceutical giant on Thursday announced its consolidated financial results for the fiscal third quarter ended December 31, 2023.Kiran Mazumdar Shaw, Executive Chairperson, Biocon and Biocon Biologics said that .

Biocon biologicsKiran mazumdar shawSiddharth mittalResearch servicesBiocon ltdMazumdar shawExecutive chairpersonEmerging marketsGeneric formulationsManaging director

Biocon denies plans to sell $1 5 billion generic API business

Biocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valued at $1.5 billion, to alleviate its debt burden. A company spokesperson clarified they were not assessing divestment options or seeking advice from bankers, countering an ET report based on insights from familiar sources.

Kiran mazumdar shawBiocon biologicsBiocon ltdBiocon limitedGeneric formulationsBiocon api businessBiocon api business saleBiocon api business valuationApi businessStake saleMergers and acquisitionsBiocon stake saleBiocon business divestment

Biocon denies reports of plan to sell generic API business, calls it baseless and speculative - Industry News

Biocon denies reports of plan to sell generic API business, calls it baseless and speculative - Industry News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Siddharth mittalEconomic timesWeighs saleBiocon limitedGeneric formulations

Biocon Biologics Ltd : Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe

Biocon Biologics Ltd : Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCzech republicBiocon biologicsStefan klotterShreehas tambePrnewswire biocon biologics ltdBiocon biologics ltdBiocon ltdUn sustainable development goals sdgsBiocon biologics ltd in europeBiologics ltdNorth americaInsulin aspartInsulin glargineCommercial europe

Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe

Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. BENGALURU, India, Nov. 30, 2023 (GLOBE NEWSWIRE) Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris’ biosimilars business in 31 European countries has been successfully completed. Following the acquisitio

United kingdomCzech republicUnited statesStephanie wascoBiocon biologicsSaurabh paliwalShreehas tambeSeema ahujaBiocon biologics ltdUn sustainable development goals sdgsBiocon ltdBiocon biologics ltd in europeHead of communicationsBiologics ltdNorth americaInsulin aspart